P067 ANALYSES ON QUALITY-ADJUSTED LIFE-YEARS (QALY) IN TWO INDUCTION AND MAINTENANCE TRIALS OF CERTOLIZUMAB PEGOL IN PATIENTS WITH ACTIVE CROHN'S DISEASE
Cited by 0
Related Papers
Trends in Global Burden and Socioeconomic Profiles of Atrial Fibrillation and Atrial Flutter: Insights from the Global Burden of Disease Study 2021
|CJC Open|2024|20
P533 Correlation of endoscopic and clinical endpoints during induction therapy in patients with moderate-to-severe Crohn’s disease: Analysis from CELEST study
|Journal of Crohn s and Colitis|2018|3
A Mysterious ST Elevation
|JAMA Internal Medicine|2025|2
822 THE CLINICAL FEATURES AND OUTCOME OF ACUTE LIVER FAILURE (ALF) IN MALAYSIA
|Journal of Hepatology|2010|1